As the overexpression of BCAT1 is found in LSCs in TET2/Isocitrate dehydrogenase (IDH) wild-type acute myeloid leukemia [48,49], BCAT1 has been proposed as a driver of LSC self-renewal through its reduction of TET2 activity. Here, BCAT1 is linked to acute myeloid leukemia.